What amount sold does EpiVax Therapeutics, Inc. report in Form D filings?

The latest linked filings report $2.6M sold across 4 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was EpiVax Therapeutics, Inc.'s most recent SEC filing?

EpiVax Therapeutics, Inc.'s most recent Form D filing was on 2021-02-22.

How many investors does EpiVax Therapeutics, Inc. have?

The most recent Form D filing lists 16 investor(s).

What type of securities does EpiVax Therapeutics, Inc. offer?

EpiVax Therapeutics, Inc.'s SEC Form D filings indicate equity offerings.

EpiVax Therapeutics, Inc.

CIK: 0001724741·Biotechnology·Providence, RI·Corporation·Founded 2017

Reported Sold

$2,574,881

Total Filings

Identified Offerings

Last Filed

Feb 22, 2021

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Feb 22, 2021Form D — New notice

Reported sold: $425,000 · Target: $3,000,000

Rule 506(b)·6 investors

Feb 22, 2021Form D — New notice

Reported sold: $369,881 · Target: $369,881

Rule 506(b)·16 investors

Oct 7, 2019Form D — New notice

Reported sold: $375,000 · Target: $1,250,000

Rule 506(b)·5 investors

Dec 14, 2018Form D/A — Amendment

Reported sold: $1,405,000 · Target: $2,000,000

Rule 506(b)·14 investors

Changed: Reported amount sold, Reported investors

Dec 11, 2017Form D — New notice

Reported sold: $50,000 · Target: $2,000,000

Rule 506(b)·1 investor

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

20%

Latest reported sold across 4 identified offerings

$2,574,881

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

William Martin

Related Person

Appears on 5 filings

Anne De Groot

Related Person

Appears on 5 filings

Clifford Grimm

Related Person

Appears on 3 filings

Daniel Adams

Related Person

Appears on 3 filings

Richard Lipkin

Related Person

Appears on 2 filings

Gad Berdugo

Related Person

Appears on 2 filings

Gad Berdugo

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Feb 22, 2021	New	$369,881	$369,881	16
Feb 22, 2021	New	$3,000,000	$425,000	6
Oct 7, 2019	New	$1,250,000	$375,000	5
Dec 14, 2018	Amendment	$2,000,000	$1,405,000	14
Dec 11, 2017	New	$2,000,000	$50,000	1

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Toggle Bio

Biotechnology

Offering target: $200,000

Filed Oct 6, 2026